Earnings History Data for Cassava Sciences, Inc. (SAVA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cassava Sciences, Inc.
Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
07-11-2024 | PM | SAVA | Cassava Sciences, Inc. | 1,150 | -0.58 | -1.37 | -0.61 | Cassava Sciences GAAP EPS of -$0.58 beats by $0.30 [11/7/2024 7:59 AM] |
25.26 | -1.31 (-4.93%) |
26.41 | -0.16 (-0.60%) |
8.79 - 42.20 | 1,514,520 | 1,270,000 | 44,077 | ||
|
||||||||||||||||||
08-08-2024 | PM | SAVA | Cassava Sciences, Inc. | 1,460 | -1.28 | -0.44 | -0.63 | Cassava Sciences GAAP EPS of $0.13 [8/8/2024 8:12 AM] |
25.82 | -4.38 (-14.52%) |
29.18 | -1.02 (-3.38%) |
8.79 - 42.20 | 6,391,412 | 6,260,000 | 288,719 | ||
10-05-2024 | AH | SAVA | Cassava Sciences | 933.00 | -1.41 | -0.51 | 0.00 | Cassava Sciences GAAP EPS of -$0.43 beats by $0.03 [5/10/2024 4:07 PM] |
20.60 | 0.37 (1.83%) |
20.50 | 0.27 (1.33%) |
12.32 - 32.10 | 533,704 | 920,000 | 4,468 | ||
|
||||||||||||||||||
28-02-2024 | PM | SAVA | Cassava Sciences, Inc. | 926.26 | -0.50 | -0.40 | -0.47 | Cassava Sciences GAAP EPS of -$0.50 [2/28/2024 9:23 AM] |
22.94 | -0.06 (-0.26%) |
23.07 | 0.07 (0.30%) |
12.32 - 32.10 | 856,703 | 440,000 | 3,573 | ||
07-11-2023 | PM | SAVA | Cassava Sciences, Inc. | 1,020 | -0.61 | -0.90 | -0.51 | Cassava Sciences GAAP EPS of -$0.61 beats by $0.29 [11/7/2023 9:47 AM] |
22.27 | 0.89 (4.19%) |
21.60 | 0.22 (1.03%) |
12.32 - 45.43 | 1,105,324 | 2,170,000 | 7,486 | ||
03-08-2023 | PM | SAVA | Cassava Sciences, Inc. | 917.35 | -0.63 | -0.58 | -0.48 | Cassava Sciences GAAP EPS of -$0.63 misses by $0.05 [8/3/2023 11:07 AM] |
20.11 | -0.73 (-3.50%) |
20.76 | -0.08 (-0.38%) |
16.81 - 51.59 | 787,525 | 700,000 | 389 | ||
01-05-2023 | PM | SAVA | Cassava Sciences | 946.00 | -0.58 | -0.56 | 0.00 | Cassava Sciences GAAP EPS of -$0.58 [5/1/2023 10:41 AM] |
23.36 | 0.14 (0.58%) |
0.0 | 0.0 (0.00%) |
13.84 - 51.59 | 526,544 | 470,000 | 0 | ||
28-02-2023 | PM | SAVA | Cassava Sciences, Inc. | 1,050 | -0.47 | -0.58 | -0.35 | Cassava Sciences GAAP EPS of -$0.47 beats by $0.11 [2/28/2023 9:40 AM] |
24.70 | -0.08 (-0.32%) |
24.51 | -0.27 (-1.09%) |
13.84 - 51.59 | 689,559 | 870,000 | 4,664 | ||
07-11-2022 | PM | 9:15 AM ET (Nov 7) |
SAVA | Cassava Sciences | 1,372 | -0.51 | -0.47 | 0.00 | Cassava Sciences GAAP EPS of -$0.51 beats by $0.08 [11/7/2022 9:51 AM] |
34.04 | -1.23 (-3.49%) |
0.0 | 0.0 (0.00%) |
13.84 - 95.53 | 1,131,820 | 990,000 | 0 | |
03-08-2022 | PM | SAVA | Cassava Sciences, Inc. | 919.05 | -0.48 | -0.42 | -0.13 | Cassava Sciences GAAP EPS of -$0.48 misses by $0.06 [8/3/2022 9:26 AM] |
18.47 | -0.91 (-4.70%) |
19.30 | -0.08 (-0.41%) |
13.84 - 126.51 | 2,168,039 | 2,920,000 | 33,487 | ||
05-05-2022 | PM | SAVA | Cassava Sciences, Inc. | 832.47 | -0.44 | -0.43 | -0.09 | Cassava Sciences GAAP EPS of -$0.44 misses by $0.01 [5/5/2022 9:17 AM] |
20.72 | -0.39 (-1.84%) |
20.90 | -0.21 (-1.01%) |
18.07 - 146.16 | 802,357 | 2,060,000 | 19,624 | ||
10-11-2021 | PM | SAVA | Cassava Sciences | 3,138 | -0.24 | -0.17 | 0.00 | Cassava Sciences EPS misses by $0.09 [11/10/2021 9:18 AM] |
69.43 | -8.98 (-11.46%) |
0.0 | 0.0 (0.00%) |
6.70 - 146.16 | 5,080,843 | 11,650,000 | 0 | ||
|
||||||||||||||||||
03-08-2021 | PM | 8:30 AM ET (Aug 3) |
SAVA | Cassava Sciences, Inc. | 2,782 | -0.13 | -0.11 | 0.00 | Cassava Sciences EPS in-line [8/3/2021 8:48 AM] |
84.93 | 4.95 (6.19%) |
87.15 | 7.17 (8.96%) |
2.78 - 146.16 | 9,782,092 | 9,570,000 | 386,466 | |
|
||||||||||||||||||
21-04-2021 | PM | 8:30 AM ET (Apr 21) |
SAVA | Cassava Sciences, Inc. | 1,356 | -0.09 | -0.08 | 0.00 | Cassava Sciences EPS misses by $0.01; outlook [4/21/2021 8:43 AM] |
34.93 | 2.78 (8.65%) |
32.00 | -0.15 (-0.47%) |
1.63 - 117.54 | 2,152,654 | 1,230,000 | 24,588 | |
|
||||||||||||||||||
23-03-2021 | PM | SAVA | Cassava Sciences, Inc. | 1,478 | -0.09 | -0.05 | 0.00 | Cassava Sciences EPS misses by $0.04 [3/23/2021 9:28 AM] |
52.33 | -3.48 (-6.24%) |
54.80 | -1.01 (-1.81%) |
1.63 - 117.54 | 1,994,179 | 2,870,000 | 21,631 | ||
09-11-2020 | PM | 8:15 AM ET (Nov 9) |
SAVA | Cassava Sciences, Inc. | 261.90 | -0.06 | -0.07 | -0.04 | Cassava Sciences EPS beats by $0.01 [11/9/2020 8:27 AM] |
10.88 | 0.90 (9.02%) |
10.04 | 0.06 (0.60%) |
1.20 - 12.68 | 1,311,129 | 6,238,551 | 1,206 | |
|